BMS’ schizophrenia therapy fails in Phase III trial as an adjunctive treatment
The therapy showed a two-point reduction in total PANSS score at week six against placebo with atypical antipsychotic.
Trump tariffs: World trade ‘fragmenting into blocks’
ESCMID Global 2025: Global access issues remain for long-acting HIV injectables
Gilead reports topline data from Phase III trial of Trodelvy combo therapy
Enlivex enrols all patients in Phase II stage of knee osteoarthritis trial
Daiichi and AstraZeneca’s Enhertu shows PFS benefits in breast cancer trial
Analysis
View More
Themes
View MoreIoT can help to reduce the burden of clinical trials on patients
IoT helps to decentralise clinical trials, allowing them to become increasingly patient-centric and diverse while providing pharmaceutical companies with a higher return on investment.
More themes
Data Insights
View MoreLeading innovators with viral vectors for the pharmaceutical industry
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
GlobalData Reports
View More
Digital Magazine
View MorePharma Technology Focus Magazine
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Mastering compliance and copyright in healthcare and MedComms
MWC Barcelona 2025: Maximizing 5G network value in the age of AI
Driving bioscience innovation: How Teesside University empowers industry breakthroughs
The AI advantage in discovering new medicines